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Abstract
Brucellosis is a zoonosis of worldwide distribution with numerous animal host species.
Since the novel isolation of Brucella spp. from marine mammals in 1994 the bacteria have
been isolated from various marine mammal hosts. The marine mammal reference strains
Brucella pinnipedialis 12890 (harbour seal, Phoca vitulina) and Brucella ceti 12891 (harbour
porpoise, Phocoena phocoena) were included in genus Brucella in 2007, however, their
pathogenicity in the mouse model is pending. Herein this is evaluated in BALB/c mice with
Brucella suis 1330 as a control. Both marine mammal strains were attenuated, however, B.
ceti was present at higher levels than B. pinnipedialis in blood, spleen and liver throughout
the infection, in addition B. suis and B. ceti were isolated from brains and faeces at times
with high levels of bacteraemia. In B. suis-infected mice serum cytokines peaked at day 7.
In B. pinnipedialis-infected mice, levels were similar, but peaked predominantly at day 3
and an earlier peak in spleen weight likewise implied an earlier response. The inflammatory
response induced pathology in the spleen and liver. In B. ceti-infected mice, most serum
cytokine levels were comparable to those in uninfected mice, consistent with a limited
inflammatory response, which also was indicated by restricted spleen and liver pathology.
Specific immune responses against all three strains were detected in vitro after stimulation
of splenocytes from infected mice with the homologous heat-killed brucellae. Antibody
responses in vivo were also induced by the three brucellae. The immunological pattern of B.
ceti in combination with persistence in organs and limited pathology has heretofore not
been described for other brucellae. These two marine mammal wildtype strains show an
attenuated pattern in BALB/c mice only previously described for Brucella neotomea.
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Introduction
Brucella spp. causes brucellosis, a zoonosis of almost worldwide distribution [1]. Brucella-infec-
tion is characterized by bacterial persistence in the reticuloendothelial system and replication
of the organism in the reproductive system in primary hosts is associated with abortion and
sterility [2]. Genus Brucella consists of eleven species, the six classical species: Brucella meliten-
sis, Brucella abortus, Brucella suis, Brucella ovis, Brucella neotomae and Brucella canis [1] and
the more recently added species: Brucella pinnipedialis, Brucella ceti [3], Brucella microti [4],
Brucella inopinata [5] and Brucella papionis [6].
Brucella spp. were first reported from marine mammals in 1994 [7] and validly published as
two novel species for inclusion in the genus Brucella in 2007 as Brucella pinnipedialis and Bru-
cella ceti with pinnipeds and cetaceans as preferred hosts respectively [8]. The type strains for
these species are B. pinnipedialis NCTC 12890 (hereafter entitled B. pinnipedialis 12890), iso-
lated from the spleen of a harbour seal (Phoca vitulina) and Brucella ceti NCTC 12891 (hereaf-
ter entitled B. ceti 12891), isolated from a skin lesion on a harbour porpoise (Phocoena
phocoena) [3]. Marine mammal brucellae have later been isolated from several pinniped and
cetacean species, yet reports on the pathological findings in association to B. pinnipedialis-
infection in true seals (Phocidae) are virtually absent, and the pathological findings in associa-
tion to infection with B. ceti in harbour porpoises are scarce. In contrast, B. ceti has been iso-
lated from various lesions in dolphins, in particular from the central nervous system associated
with neurological pathology and live stranding, but also from uterus, testes, aborted foetuses,
vaginal secretions, milk and mammary glands [9–12]. Additionally, an unusual genotype
(sequence type 27, ST27) [13] only isolated thus far from bottlenose dolphins (Tursiops trunca-
tus)[14] and a California sea lion (Zalophus californianus) [15] has been shown to multiply in
human macrophages to the same degree as B. suis 1330 [16] and has also caused naturally
acquired infections in humans [17, 18]. The ST27 isolates share a unique variable number of
tandem repeats (VNTR) profile and restriction fragment length polymorphism (RFLP) analysis
of outer membrane protein 2 (omp2)–encoding genes also showed an identical genotype
among the isolates [13].
In vitro work has shown that B. pinnipedialis 12890 did not multiply in murine, human or
hooded seal (Cystophora cristata) macrophages, or in a human epithelial cell line [19, 20] and
B. ceti 12891 did not multiply in human [16] or hooded seal macrophages [20]. Other work dis-
played deviating results by showing that B. pinnipedialis 12890 was able to multiply in human
macrophages to the same extent as the virulent strains B. suis 1330 and B.melitensis 16M [16].
Experimental infection in piglets (Sus scrofa domesticus) with a marine mammal brucellae
human isolate 02/611 [18], belonging to ST27 [13], yielded no pathology [21], while abortion
has been induced in cattle (Bos taurus) after infection with a B. pinnipedialis Pacific harbour
seal (Phoca vitulina richardsi) strain [22]. Experimental infection of pregnant sheep (Ovis
aries) [23] with a B. pinnipedialis harbour seal strain and B. ceti harbour porpoise and common
dolphin (Delphinus delphis) strains [7] resulted in limited pathology, while infection in guinea
pigs (Cavia porcellus) with the same strains resulted in splenomegaly and high antibody titres
[23]. Another guinea pig study showed that B. ceti from a bottlenose dolphin foetus was less
virulent than the terrestrial strains B. abortus S19, B. abortus B3196, B.melitensis 16M and B.
melitensis 63/9 [14]. A hooded seal B. pinnipedialis strain showed reduced pathogenicity in
BALB/c mice (Mus musculus) as compared to B. suis 1330 [24].
Heretofore, in vivo experimental infections with marine mammal brucellae have been per-
formed with various strains in different animal species, under various conditions, and with
diverse and non-conclusive results [14, 21–23]. A murine model of infection for Brucella spp.,
however, is well established and much of the current understanding of the pathogenesis and
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immunity of animal brucellosis has arisen from studies in mice [25–27]. The Subcommittee on
the Taxonomy of the Genus Brucella has in the minimal standards for recognition of an organ-
ism as a member of the genus stated that pathogenicity in mice should be investigated [8]. This
work is lacking for the marine mammal reference strains. The aim of the present study was to
evaluate the pathogenicity of B. pinnipedialis 12890 and B. ceti 12891 in a BALB/c mouse
model by characterizing the evolution of the infection, histopathology and immunological
parameters.
Materials and Methods
Ethics statement
Three mouse experiments were conducted in strict accordance with the guidelines from the
Federation of Laboratory Animal Science Associations and were approved by the Agrifood
Research and Technology Centre of Aragon (CITA) ethical animal experiment committee. No
mice died during the experiments. The main (I) murine infection (comprising bacteriology,
histopathology, serum antibody isotypes and serum cytokines) lasted for 12 weeks and is
described under “Murine infections”, section one (experiment number: I118/2010/1). A sup-
plementary murine infection (II), for the detection of early serum cytokines, lasting for three
days, is described under “Murine infections”, section two (experiment number: I124/2014/2).
A third mouse experimental infection (III), lasting for 7 days, was performed to do an in vitro
splenocyte experiment for the detection of supernatant cytokines after stimulation in vitro with
heat-killed (HK) brucellae. This is described under “In vitro splenocyte cytokine responses fol-
lowing antigen stimulation” (experiment number: I125/2014/12).
Bacterial strains
The strains studied were the marine mammal reference strains B. pinnipedialis sp. nov. (NCTC
12890T, BCCN 94-73T) and B. ceti sp. nov. (NCTC 12891T, BCCN 94-74T) [3] (kindly pro-
vided by Dr. Cloeckaert and Dr. Zygmunt, The INRA Val de Loire Centre, Nouzilly, France).
Brucella suis biovar 1 strain 1330 (NCTC 10316, ATCC 23444, from now on entitled B. suis
1330) was included as a classical Brucella control. The marine mammal strains were grown on
blood agar base N°2 (BAB) (Oxoid, Basingstoke, UK) with 5% newborn calf serum (NCS)
(Pan-Biotech GmbH, Aidenbach, Germany) and B. suis 1330 was grown on BAB, if otherwise
is not specified. All strains were incubated aerobically at 37°C (B. pinnipedialis 12890 in a 5%
CO2 enriched atmosphere). The expression of smooth surface antigens was verified by crystal
violet staining [28]. The identity of the bacteria grown from organ samples was verified by
polymerase chain reaction (PCR), as previously described [24] (results not shown).
Murine experiments
In the main murine infection, lasting for 12 weeks, eight week old female BALB/c mice (Charles
River Laboratories, L'Arbresle Cedex, France) were injected intraperitoneally (ip) with 100 μl
sterile phosphate buffered saline (sPBS) holding 105 colony forming units (CFU) of B. pinnipe-
dialis 12890, B. ceti 12891 or B. suis 1330. To prepare the infective solution the strains were
grown for 48 (marine mammal strains) or 24 hrs (B. suis 1330) and thereafter diluted in sPBS.
Uninfected control mice received 100 μl sPBS ip. Four or five mice were euthanized by CO2
asphyxiation per lot at day 3, 7, 14, 21, 35, 56 and 84 post infection (pi) (day 56 and 84; only B.
ceti 12891 and B. suis 1330). Spleen, liver, brain and faecal samples were collected aseptically
and weighted. Blood was sampled by cardiac puncture. A portion of the blood was used for
bacteriology while the rest was centrifuged (3,000 rpm, 15 min, RT°) to obtain serum. Sera
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were passed through 0.2 μmAcrodisc Syringe Filters with Supor Membrane (Pall Corporation,
NY, USA) and stored at -80°C.
As mice infected with B. ceti 12891 produced a limited serum cytokine response on day 3, 7
and 14 pi (see “Results”, “Serum cytokines”) we performed an additional murine infection,
identical to the main murine infection described above, but lasting only for three days, for the
detection of early (day 1, 2 and 3 pi) serum cytokines. Eight week old female BALB/c mice (Jan-
vier Labs, Le Genest-Saint-Isle, France) were injected ip with 105 CFU of B. pinnipedialis
12890, B. ceti 12891 or B. suis 1330. Uninfected control mice were treated as described above.
Four or five mice were euthanized per lot at day 1, 2 and 3 pi and spleen and serum samples
were collected as described above. From these mice spleen bacterial loads (to verify that the
level of infection was comparable to that in the main investigation) and serum cytokine levels
were investigated.
Bacteriology
Weighed portions of spleen, liver and brain from mice infected with B. pinnipedialis 12890, B.
ceti 12891 or B. suis 1330 in the main investigation were homogenized, serially diluted and
plated (marine mammal strains; BAB + 5% NCS/B. suis 1330; BAB) for evaluation of the num-
ber of CFU. Faecal samples were treated the same way, but were plated on modified Farrell
medium (one vial of Brucella selective supplement (Oxoid) per BAB litre + 5% NCS). Blood
was plated for the evaluation of CFU as described above. The numbers of bacterial counts were
logarithmic transformed (except for the faeces results) and expressed as mean + one standard
deviation (SD). When no colonies were detected a limit of detection of at least one colony was
assigned for the log conversion.
Histopathology
Mice infected with B. pinnipedialis 12890, B. ceti 12891 or B. suis 1330 in the main investigation
and uninfected control mice, were examined at sacrifice for gross pathology. Samples of spleen,
liver and brain were kept in 4% formaldehyde in sPBS until processing. Samples examined
from all animals included three sections from the right and left hepatic lobes as well as the
right middle lobe, including the gallbladder and one section of spleen. Three transverse sections
of the brain, including portions of cortex, corpus callosum, hippocampus, pons and cerebellum,
were examined. Fixed tissues were embedded in paraffin, cut in 4 μm sections and stained with
haematoxylin and eosin for histopathological examination. Sections were analysed blinded for
light microscopy analysis, and the main lesions were counted and described in all stained sec-
tions by a Diplomat of the American College of Veterinary Pathologists.
Serum antibody isotypes
Serum samples from mice infected with B. pinnipedialis 12890, B. ceti 12891 or B. suis 1330 in
the main investigation were tested for the levels of antibody isotypes, immunoglobulin (Ig) M,
IgG1, IgG2a and IgG3, with enzyme-linked immunosorbent assays (ELISAs) with B. abortus
lipopolysaccharide as antigen, as previously described [24]. The results are expressed as mean
optical density (od) + one SD.
Serum cytokines
Serum levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin
(IL)-1β, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, IL-2, IL-12 (p40/p70), IL-4, IL-5,
IL-6 and IL-10 were determined in mice infected with B. pinnipedialis 12890, B. ceti 12891 or
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B. suis 1330 utilizing the Cytokine Mouse 10-Plex Panel (Invitrogen) on the Luminex 100™ ana-
lyzer (Luminex Corporation, Austin, TX, USA). Sera from day 3, 7 and 14 pi were analysed
during the main murine infection (“Murine infections”, section one). Sera from day 1, 2 and 3
pi were analysed during an additional murine infection performed for the detection of early
serum cytokines (“Murine infections” section two), with the same Cytokine Mouse 10-Plex
Panel. Serum cytokines and spleen bacterial load on day 3 pi were analysed during both experi-
ments to ensure coherence. Serum cytokine levels are presented as mean levels in pg/ml + one
standard error of the mean (SEM).
In vitro splenocyte cytokine responses following antigen stimulation
In a separate, third, experiment, BALB/c mice were infected with B. pinnipedalis 12890, B. ceti
12891 or B. suis 1330, as described under “Murine infections”. On day 7 pi a suspension of sple-
nocytes from infected and uninfected mice were obtained as formerly described [29] and cul-
tured in 24-well sterile plates (2 x 106 cells/well). Splenocytes from mice infected with B.
pinnipedalis 12890, B. ceti 12891 or B. suis 1330 were subsequently either stimulated with the
homologous HK B. pinnipedalis 12890, HK B. ceti 12891 or HK B. suis 1330, at a multiplicity of
infection of 100, or left unstimulated. Splenocytes from uninfected mice were stimulated with
the three strains of HK brucellae, or left unstimulated. Additionally, splenocytes from infected
and uninfected mice were stimulated with LPS from Escherichia coli serotype O55:B5 (Sigma
Aldrich, Madrid, Spain) 100ng/ml. Spleen cells were incubated at 37°C in a 5% CO2 enriched
atmosphere for 72 h as described [29], after which supernatants were harvested, centrifuged
(1,200 RPM, 5 min, RT°), passed through 0.2 μmAcrodisc Syringe Filters with Supor Mem-
brane (Pall Corporation), and used for measuring IFN-γ, TNF-α and IL-6 levels with the
Ready-Set-Go! ELISA kits from eBioscience (San Diego, CA, USA). The experiment was
repeated twice and the results are presented together. Results are presented as mean level of
cytokines in pg/ml + one SEM.
Statistics
All comparisons were made by an unpaired two-tailed Student t-test. P values< 0.05 were con-
sidered significant.
Results
Bacteriology and organ weights
The spleen and liver bacterial counts (Fig 1a and S1 Fig) and weights (Fig 1b and S1 Fig) in
mice infected with B. suis 1330 were similar to those described in the literature [30]. The num-
bers of CFU in the spleens of mice infected with the marine mammal brucellae reference strains
were significantly lower than those found in mice infected with B. suis 1330 at all times pi
(p< 0.001), except for mice infected with B. ceti 12891 at day 14, where there was no signifi-
cant difference (Table 1). Mice infected with B. pinnipedialis 12890 showed an increase in
spleen CFU between day 3 (5.13 log CFU ± 0.37) and 7 (6.05 log CFU ± 0.17) and a subsequent
decline reaching 1.22 log CFU (± 1.02) at day 35. The spleen bacterial counts in mice infected
with B. ceti 12891 followed the same pattern as that of mice infected with B. pinnipedialis
12890 at day 3 and 7, while at day 14 (p< 0.001), 21 (p< 0.001) and 35 (p< 0.01) the spleen
CFU numbers were significantly higher in mice infected with B. ceti 12891, as compared to
those infected with B. pinnipedialis 12890 (Fig 1a). The spleen weight in mice infected with B.
pinnipedialis 12890 peaked at day 7 and at day 35 the spleen weights did not differ significantly
from those found in uninfected control mice. The spleen weight of mice infected with B. ceti
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12891 peaked at day 14 and at day 35 the weights did not differ significantly from those found
in uninfected control mice (Fig 1b and S1 Table). In the liver we observed the same patterns for
bacterial counts (S1 Fig and Table 1) and weights (S1 Fig and S1 Table) as in the spleen, con-
firming the attenuation of the marine mammal reference strains in the BALB/c mouse model.
The bacteraemia induced by B. suis 1330 was more pronounced and longer lasting than that
induced by the marine mammal reference strains (Table 1 and S2 Fig). The log number of
CFU/ml blood for mice infected with B. pinnipedialis 12890 peaked at day 7 (1.69 log CFU/ml
blood ± 1.36) and mice infected with this strain showed no signs of bacteraemia thereafter.
Mice infected with B. ceti 12891 showed two peaks, at day 3 (1.50 log CFU/ml blood ± 0.88)
and at day 14 (1.10 log CFU/ml blood ± 1.51) and displayed bacteraemia until at least day 35.
Brucellae were isolated from the brains of mice infected with B. suis 1330 at day 3 (0.39 log
CFU/g brain ± 0.87) and 7 (1.60 log CFU/g brain ± 1.03) and from mice infected with B. ceti
Fig 1. Spleen bacterial counts and organ weights. Bacterial counts for B. pinnipedialis 12890 (open
diamonds), B. ceti 12891 (crosses) and B. suis 1330 (black squares) in spleens (a) of BALB/c mice after
intraperitoneal (ip) inoculation of 105 colony forming units (CFU) of bacteria. Uninfected control mice received
sterile phosphate buffered saline ip (black lines). Four or five mice were euthanized per lot at day 3, 7, 14, 21,
35, 56 and 84 post infection (day 56 and 84; only B. ceti 12891 and B. suis 1330). The number of viable
bacteria was determined and the numbers of bacterial counts were logarithmic transformed. Spleen weights
(b) were determined in parallel. Results are expressed as mean + one standard deviation. Whether CFU
numbers differed significantly between mice infected with B. suis 1330, and B. ceti 12891 or B. pinnipedialis
12890, respectively, at the different times pi, are presented in Table 1. Whether spleen weights of the infected
mice were significantly different from those of the uninfected control mice, at the different times pi, is
presented in S1 table.
doi:10.1371/journal.pone.0150432.g001
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12891 at day 14 (1.61 log CFU/g brain ± 1.01). Brucellae were also isolated from faecal samples
of mice infected with B. suis 1330 from day 3 to 35 and from mice infected with B. ceti 12891 at
day 14 (S2 Fig). Brucella pinnipedialis 12890 was isolated from neither brain nor faeces. There
were no significant differences in the log number of CFU/g of brain or faeces between the mice
infected with B. suis 1330 and B. ceti 12891.
Histopathology
Pathological findings in the spleen and liver of BALB/c mice infected with B. pinnipedialis
12901, B. ceti 12891 or B. suis 1330 are summarized in Table 2 (day 3–84 pi) and pictures of
spleen and liver histopathology at day 14 are presented in S3 Fig. Except for the enlargement of
spleen and liver, no gross pathology was observed.
Table 1. Level of statistical difference when comparing numbers of colony forming units in BALB/mice infected with Brucella suis 1330 to those
infected with the marinemammal reference strains.
Day 3 7 14 21 35 56 84
Spleen CFU Brucella pinnipedialis 12890 *** *** *** *** *** X X
Brucella ceti 12891 *** *** ns *** *** *** ***
Liver CFU Brucella pinnipedialis 12890 *** ** *** *** *** X X
Brucella ceti 12891 *** ns ns *** ** ** ***
Blood CFU Brucella pinnipedialis 12890 ns ** X X X X X
Brucella ceti 12891 ns *** ** ** ns X X
Level of statistical difference between the number of colony forming units (CFU) in spleen, liver and blood of BALB/c mice after intraperitoneal (ip)
inoculation of 105 colony forming units (CFU) of B. suis 1330, B. pinnipedialis 12890 or B. ceti 12891. Four or five mice were euthanized per lot at day 3,
7, 14, 21, 35, 56 and 84 post infection (day 56 and 84; only B. ceti 12891 and B. suis 1330). Mice infected with B. ceti 12891 or B. pinnipedialis are
compared to mice infected with B. suis 1330 and *** = p < 0.001, ** = p < 0.01, * = p < 0.05, ns = not significant, X = not available.
doi:10.1371/journal.pone.0150432.t001
Table 2. Histopathological findings in spleen and liver.
Day B. suis 1330 B. pinnipedialis 12890 B. ceti 12891
Spleen Liver Spleen Liver Spleen Liver
3 +/- (2/2) ++/- (3/1) - +/- (2/3) - -
7 * ++ * ++ + -
14 * +++ + ++ + +
21 ++ +++ + +/- (2/3) +/- (2/3) +/- (2/3)
35 ++ ++/- (4/1) - - - -
56 + ++ X X - -
84 + (2/3) +/- (3/2) X X - -
Spleen and liver pathology in BALB/c mice after intraperitoneal (ip) inoculation of 105 colony forming units (CFU) of B. pinnipedialis 12890, B. ceti 12891
or B. suis 1330. Uninfected control mice received sterile phosphate buffered saline ip. Four or five mice were euthanized per lot at day 3, 7, 14, 21, 35, 56
and 84 post infection (day 56 and 84; only B. ceti 12891 and B. suis 1330). The pathological changes in spleen were graded as follows;—: no pathological
changes, *: expansion of the red pulp and lymphoid depletion, +: follicular hyperplasia, and ++: splenomegaly with expanded red and white pulp and
granulomas. The pathological changes in liver were graded as follows;—: no pathological changes, +: livers with few inflammatory nodules without
necrosis, ++: livers containing inflammatory nodules with up to 10 cells present, +++: livers with large inflammatory nodules, with or without necrosis.
When only some of the animals had lesions this is indicated by showing one or more + and a—; additionally, the number of animals with and without
lesions, respectively, are shown in brackets. X = not avaliable.
doi:10.1371/journal.pone.0150432.t002
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Splenic lesions were most pronounced in mice infected with the virulent B. suis 1330. They
were characterized by splenomegaly with expansion of the red pulp and diminished white pulp
(follicular lymphoid depletion) followed by a marked follicular hyperplasia (reactive nodules)
mixed with granulomas after day 14. Mice infected with the marine mammal reference strains
showed less severe splenic pathology than those infected with B. suis 1330, with mainly reactive
lymphoid follicles and very few small granulomas. Mice infected with B. pinnipedialis 12890
displayed lesions in all mice at day 7, 14 and 21, with expansion of the red pulp and lymphoid
depletion at day 7 and follicular hyperplasia at day 14 and 21, while at day 35, no pathology
could be detected. The pathological changes in the spleens of mice infected with B. ceti 12891
were less severe than in mice infected with B. pinnipedialis 12890. The B. ceti 12891-infected
mice displayed follicular hyperplasia in all mice at day 7 and 14, in 40% of the mice at day 21
and no pathology at day 35.
Hepatic granulomas were consistently found in all mice with lesions, irrespective of the
strain of Brucella that they were exposed to (Table 2 and S3 Fig). Characteristic variably sized
inflammatory nodules containing macrophages in place of hepatocytes were found in all
affected animals. The strain causing the most severe hepatic pathology was B. suis 1330. A
majority of the mice (75%) infected with B. suis 1330 showed pathological changes starting at
day 3. Granulomatous lesions were found in 60% of the mice until at least day 84. The lesions
at day 35 and 56 showed necrosis associated to the inflammatory nodules, but necrosis was not
observed at day 84. Mice infected with B. pinnipedialis 12890 showed less severe liver lesions
than those infected with B. suis 1330 at day 3 and only 40% of the mice were affected. At day 7
and 14 all mice infected with B. pinnipedialis 12890 showed inflammatory nodules, however,
by day 35 there was no liver pathology present. Mice infected with B. ceti 12891 exhibited only
minimal pathologic changes at day 14 (100%) and 21 (40%) and the lesions were resolved by
day 35. These changes included small inflammatory nodules with no necrosis.
Brains of all infected animals were examined and no pathological changes were detected.
Liver, spleen and brain tissues from uninfected control mice were also examined and no patho-
logical lesions were observed.
Serum antibody isotypes
There was some variation in the od levels of individual mice, leading to certain sizeable SDs
(Fig 2). The mean od levels of the uninfected mice were below 0.072 at all times for all antibody
isotypes. The IgM (Fig 2a), IgG1 (Fig 2b), IgG2a (Fig 2c) and IgG3 (Fig 2d) patterns in mice
infected with B. suis 1330 were as described previously for virulent brucellae [24, 26, 31]. Mice
infected with B. pinnipedialis 12890 and B. ceti 12891 produced patterns similar to those found
for B. suis 1330, however, mice infected with B. pinnipedialis 12890 and B. ceti 12891 produced
a significantly higher IgM response at day 14 (p< 0.001 and p< 0.01) and IgG3 response at
day 21 (p< 0.05) than those infected with B. suis 1330. At day 21, mice infected with B. pinni-
pedialis 12890 produced a significantly higher IgG1 response than those infected with B. suis
1330 (p< 0.05). There were no significant differences in the IgG2a od values between mice
infected with B. suis 1330 and the marine mammal reference strains. None of the isotype od
values were significantly different between the mice infected with the two marine mammal ref-
erence strains.
Serum cytokines
Sera from day 3, 7 and 14 pi were analysed during the main murine infection (“Murine infec-
tions”, section one) (Fig 3), while sera from day 1, 2 and 3 pi were analysed during an addi-
tional murine infection performed solely for the detection of early serum cytokines (“Murine
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Fig 2. Serum antibody isotypes. Serum antibody isotype patterns for immunoglobulin (Ig) M (a), IgG1 (b),
IgG2a (c) and IgG3 (d) in BALB/c mice after intraperitoneal (ip) inoculation of 105 colony forming units (CFU)
of B. suis 1330 (black), B. pinnipedialis 12890 (light grey), B. ceti 12891 (dark grey) or B. pinnipedialis 12890
(light grey). Uninfected mice received sterile phosphate buffered saline ip (white). Four or five mice were
euthanized per lot at day 3, 7, 14, 21, 35, 56 and 84 post infection (day 56 and 84; only B. ceti 12891 and B.
suis 1330). Data are presented as mean optical density + one standard deviation. The marine mammal
reference strains were compared to B. suis 1330 and *** = p < 0.001, ** = p < 0.01, * = p < 0.05.
doi:10.1371/journal.pone.0150432.g002
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Fig 3. Serum cytokines. Serum levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) (a),
interleukin (IL)-1β (b), tumor necrosis factor (TNF)-α (c), interferon (IFN)-γ (d), IL-2 (e), IL-12 (p40/p70) (f), IL-
4 (g), IL-5 (h), IL-6 (i) and IL-10 (j) in BALB/c mice, after intraperitoneal (ip) inoculation of 105 colony forming
units (CFU) of B. pinnipedialis 12890, B. ceti 12891 or B. suis 1330. Uninfected mice received sterile
phosphate buffered saline ip. Four or five mice were euthanized per lot at day 3, 7 and 14 post infection.
Results are expressed as mean serum cytokine levels in pg/ml + one standard error of the mean. The marine
mammal reference strains were compared to B. suis 1330 and *** = p < 0.001, ** = p < 0.01, * = p < 0.05.
doi:10.1371/journal.pone.0150432.g003
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infections” section two). Serum cytokines and spleen bacterial load on day 3 pi were analysed
during both experiments and neither the spleen bacterial loads, nor the serum cytokine levels
for the different strains at day 3, were significantly different between the two experiments
(results not shown). The cytokines on day 1 and 2 were similar to those found in the uninfected
mice and the results are hence not shown. In mice infected with B. suis 1330, sampled at day 3,
7 and 14, the cytokine levels peaked at day 7 for all cytokines. In mice infected with B. pinnipe-
dialis 12890 the cytokine levels were similar to those found for B. suis 1330 but peaked at day 3,
except IL-12 (day 7) and IL-5 (low levels at all times, similar to the uninfected mice). Brucella
ceti elicited a slight increase in IL-12 at day 7 and 14. Otherwise the cytokine levels in mice
infected with B. ceti 12891 were similar to those found in the uninfected mice (Fig 3).
In vitro splenocyte cytokine responses following antigen stimulation
In vitro splenocyte cultures from mice 7 days pi were stimulated with the homologous HK B.
pinnipedalis 12890, HK B. ceti 12891 or HK B. suis 1330, and 72 h later cell supernatants were
evaluated for IFN-γ, TNF-α and IL-6 (S4 Fig). Splenocytes from mice infected with B. pinnipe-
dalis 12890, B. ceti 12891 or B. suis 1330 and stimulated with the homologues HK strain pro-
duced significantly more IFN-γ, TNF-α and IL-6 than the splenocytes from mice infected with
B. pinnipedalis 12890, B. ceti 12891 or B. suis 1330 stimulated with E. coli LPS or left unstimu-
lated (S4 Fig).
Discussion
The pathogenicity of the marine mammal reference strains, B. pinnipedialis 12890 and B. ceti
12891 were studied in a BALB/c mouse model. For the recognition of an organism as a member
of the genus Brucella pathogenicity in mice should be investigated, and the present studies fulfil
this requirement [8]. The information from experimental infections in mice is not directly
applicable to humans or target animal species and the ideal approach to reveal the infection
biology of Brucella spp. would be to test the different strains in their natural hosts, but this is
impractical and costly, especially when working with strains originating from wild animals,
however, by using an appropriate protocol, experiments may yield useful information, allowing
comparison of strains [26].
The sole previous experimental infection with a marine mammal Brucella spp. in BALB/c
mice was with a B. pinnipedialis hooded seal strain [24]. Molecular studies have characterized
the hooded seal B. pinnipedialis as diverging from other pinniped brucellae, however, a similar
lack of Brucella-associated pathology [10] and an age-dependent serological and bacteriological
pattern, with a low probability of being positive for pups, a higher probability for yearlings, fol-
lowed by a decreasing probability with age, is identified in both hooded and harbour seals [32,
33, 34]. Yet, when comparing spleen weight in BALB/c mice following experimental infection,
there was a discrepancy between the two Brucella strains; B. pinnipedialis hooded seal strain
induced no alteration in spleen weight [24], while B. pinnipedialis 12890 induced an increase in
spleen weight at day 7–21. Moreover, when comparing spleen CFU in the same model, there
was a difference between B. pinnipedialis hooded seal strain [24] and B. pinnipedialis 12890 at
day 7, while the numbers thereafter were comparable. Based on a similar behaviour in their
host species [32, 33, 34], previous experimental results for B. pinnipedialis hooded seal strain in
BALB/c mice [24] and with the aim of keeping animal experiments to a minimum [35], B. pin-
nipedialis 12890 was studied only until day 35 in the present study.
The marine mammal reference strains, B. pinnipedialis 12890 and B. ceti 12891, presented
attenuated spleen and liver bacterial counts in a BALB/c mouse model of infection and the
attenuation was furthermore indicated by the lesser increase in spleen and liver weight, as
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compared to B. suis 1330. To our knowledge, the only other wildtype strain attenuated in the
mouse model is B. neotomae, which is considered as not being virulent in its rodent host and
having a limited zoonotic potential [36]. This is comparable to the absence of, or limited and
unspecific, pathology reported in harbour seals and harbour porpoises infected with B. pinnipe-
dialis and B. ceti and the lack of reports of zoonotic incidents [10] among people handling or
consuming marine mammals [37].
During the acute phase, extending from day 3 to the time when the CFU reach their highest,
brucellae are reported to be readily isolated from blood [26], as shown in the B. suis 1330
infected mice in the present study. Bacteraemic episodes during the chronic steady phase, how-
ever, are said to be transient and scarce [26], yet B. suis 1330 was isolated from the blood at all
times until at least day 56, but the levels after day 21 were low. The longer lasting bacteraemia
in the B. ceti 12891-infected mice than in those infected with B. pinnipedialis 12890 was in
coherence with the lower level and quicker elimination of infection in the B. pinnipedialis
12890-infected mice, as compared to those infected with B. ceti 12891.
The bacteriological presence of brucellae in the mouse brain, detected through direct cul-
ture, has not been investigated previously, however, the observed behaviour of Brucella-
infected mice during experimental infections [26], including in the present study, does not sug-
gest brain pathology, as has been documented in humans [38], ungulate foetuses [39] and dol-
phins [11] where neurobrucellosis is a common clinical trait. Even though the mouse model
might not be the appropriate animal model for studying neurobrucellosis and the information
from experimental infections in mice is not directly applicable to target animal species [26], the
occurrence of neurobrucellosis in dolphins infected with B. ceti [11] was the rationale for inves-
tigating brain tissue in the present study. Brucella suis 1330 and B. ceti 12891 were isolated
from brain tissue at times pi when the number of bacteria in the blood was at its highest. Stud-
ies point to a relationship between the level of bacteraemia and brain infection for certain path-
ogens, however, a high bacteraemia level is necessary, but not sufficient, for haematoencephalic
barrier adhesion and traversal [40]. The number of bacteria isolated from the brains was maxi-
mum 1.61 log CFU/g brain, corresponding to 40.74 CFU/g brain. As the mouse brain is
approximately 0.4 g [41] this accounts for 16.30 CFU/brain, which would be a very low level of
infection. Moreover, we did not detect any brain pathology in the three brain sections studied
per mice and contamination of the brains with blood during sampling cannot be excluded. Yet,
mice infected with B. pinnipedialis 12890 had bacteria in the blood at certain times pi and B.
pinnipedialis 12890 was not isolated from the brains. The use of bioluminescent strains and
hence higher ip dosages [42], complemented with direct culture from the organs, could in
future provide further knowledge regarding dissemination and tissue localization of marine
mammal brucellae in mouse models.
Brucellae were isolated from faecal samples of mice infected with B. suis 1330 and B. ceti
12891. Faecal excretion of brucellae has been shown previously in mice following oral infection
[43], however, to our knowledge, faecal excretion following ip inoculation has not been
described. The isolation of brucellae from faeces coincided with the times when the mice had
bacteraemia. Contamination with blood during sampling cannot be excluded, as the faeces
were extracted from the large intestine by a mechanical procedure that could have damaged
the intestinal blood vessels. Cattle have been shown to shed B. abortus in faeces [44] and B. pin-
nipedialis has been isolated from Pacific harbour seal faeces [32]. The transmission of marine
mammal brucellae is still unknown, but the recent publication of a multiplex real-time PCR
assay for the detection of brucellae in faeces from marine mammals [45] may shed some light
on the role of faecal excretion in the marine mammal brucellae epidemiology.
A detectable increase in the levels of cytokines in serum is indicative of an inflammatory
pathogenic process [46]. Most of the lesions observed during brucellosis are a result, either
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directly or indirectly, of the inflammatory phenomena elicited by Brucella spp. [47]. Brucella
suis 1330 and B. pinnipedialis 12890 induced similar levels of serum cytokines and both strains
produced spleen and liver pathology, indicating that the observed production of cytokines
induced tissue damage. The lesions in the B. suis 1330-infected mice were similar to those
described previously for the virulent strains B. abortus 2308 in BALB/c mice [48] and B.microti
in C57BL/6 mice [49]. The spleen and liver lesions were most pronounced in mice infected
with B. suis 1330, while the pathological changes in mice infected with B. pinnipedialis 12890
were moderate and transient, similar to those described previously for attenuated brucellae in
BALB/c mice [26]. Brucella ceti 12891 induced less severe spleen and liver pathology, in fewer
mice, than B. pinnipedialis 12890 and the onset of liver pathology was later, indicating a less
pronounced inflammatory response towards B. ceti as compared to that towards B. pinnipedia-
lis 12890. To our knowledge this is the first description of spleen and liver histopathology in B.
suis 1330-infected BALB/c mice, as well as in BALB/c mice infected with the marine mammal
reference strains.
Defence against microbes is mediated by the early innate immunity and the later responses
of the adaptive immunity and there is a delay of 4–7 days before the adaptive immune response
takes effect [50]. GM-CSF, IL-1β, TNF-α, IFN-γ, IL-2 and IL-6 are important pro-inflamma-
tory cytokines, part of the nonspecific innate immune response that serves as the first line of
defence [46]. The current study showed peaks in serum levels of these cytokines at day 7 pi in
the B. suis 1330-infected mice, as previously described in BALB/c mice infected with B. abortus
2006018 isolated from a Chinese patient [51] and B. abortus 2308 [26], whilst in the B. pinnipe-
dialis 12890-infected mice these cytokines peaked at day 3 pi. Furthermore, when splenocyte
cultures from infected mice were stimulated with the homologous HK Brucella and the cell
supernatants were evaluated for IFN-γ, TNF-α and IL-6, both B. suis 1330 and B. pinnipedialis
12890 produced significantly more cytokines than the splenocytes from infected mice stimu-
lated with E. coli LPS or left unstimulated, confirming that both strains elicit a release of these
cytokines in response to specific stimulation also in vitro. The results presented here suggest
that B. pinnipedalis 12890 might lack some of the virulence factors present in B. suis 1330
which allow the latter to escape the immune response and establish a chronic infection more
efficiently [2].
IL-12 bridges innate resistance and adaptive immunity [52] and primes the Th1 immune
response characteristic for adaptive immunity against Brucella spp. [25]. IL-12/β2-microglobu-
lin knockout mice infected with B. abortus 2308 have shown increased numbers of bacterial
load in spleens as compared to C57BL/6 mice [53] and administration of anti-IL-12 monoclo-
nal antibodies to B. abortus 19 infected CBA mice led to an exacerbation of the infection [54].
Previous studies have shown a peak in serum levels of IL-12 in BALB/c mice infected with B.
abortus 2308 at around 7 days pi [25] and the same pattern was observed for both B. suis 1330
and B. pinnipedialis 12890 in the current study indicating a priming of the Th1 immune
response in mice infected with both strains. Indeed, the cytokine patterns in vivo for the Th2
cytokines IL-4, IL-5 and IL-10 followed a similar pattern for B. suis 1330 and B. pinnipedialis
12890 in the current study, with not significantly different levels at day 3, 7 and 14 pi.
The earlier cytokine response in the B. pinnipedialis 12890-infected mice is followed by a
reduced level of cytokines at day 7 pi as compared to B. suis 1330. This is a time pi when the
adaptive immunity has taken effect [50] and Brucella spp. typically express Th1-cytokines, as
shown for B. suis 1330 in the present study. However, one may speculate whether the prompt
inflammatory reaction towards B. pinnipedialis 12890, as shown by the cytokine profiles in
vivo and in vitro, the earlier peak in spleen weight and the inflammatory responses in the spleen
and liver, may have been efficient to a level where a Th1 response is induced to a lesser extent.
Experimental infections with B. pinnipedialis 12890 in mice with mutations in genes coding for
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key factors of the innate and adaptive immune response could provide further insight into the
properties of the immune response towards B. pinnipedialis 12890 in the mouse model.
The prompt immune response and the clearance of infection in the BALB/c mouse model,
however, is comparable to what is seen in harbour seals, where age-dependent serological and
bacteriological patterns for B. pinnipedialis have been identified, with a low probability of
being positive for pups, a higher probability for yearlings, followed by a decreasing probability
with age, suggesting clearance of infection [32, 33]. The same pattern has also been identified
in hooded seals [34], hence, B. pinnipedialis could be causing an acute transient infection in
pinnipeds, which could also explain the limited gross pathology [10] found in pinnipedis
infected with B. pinnipedialis.
The serum cytokine levels in mice infected with B. ceti 12891 were similar to those found in
the uninfected mice. However, when splenocyte cultures from B. ceti 12891-infected mice were
stimulated with the homologous HK Brucella and the cell supernatants were evaluated for
IFN-γ, TNF-α and IL-6, splenocytes produced significantly more cytokines than the spleno-
cytes from infected mice stimulated with E. coli LPS or left unstimulated, confirming that the
BALB/c mouse immune system is able to mount a specific immune response against B. ceti
12891, as well as B. pinnipedialis 12890 and B. suis 1330. The antibody isotype levels also con-
firm the presence of an immune response against all three strains of brucellae. The immunolog-
ical pattern described for B. ceti 12891, in combination with persistence in the organs with
limited signs of pathology, has heretofore not been seen for any other species of brucellae and
further investigations are needed to draw any conclusions regarding the immunological
response in the BALB/c mouse model to B. ceti 12891. The predominantly similar antibody iso-
type patterns between the virulent B. suis 1330 and the attenuated marine mammal reference
strains was as previously described for virulent and attenuated strains of brucellae [31].
In dolphins, B. ceti has been isolated from lesions in the reproductive systems, and from
aborted foetuses, vaginal secretions, milk and mammary glands, and in addition, several times
from the CNS associated with neurological pathology. Further investigations should be made
in the mouse model with B. ceti dolphin strains, as pathology has been described in the natural
host [11]. In contrast, there are some reports of pathology in porpoises in association to infec-
tion with B. ceti, but the number of incidences are fewer, in general less severe and with unspe-
cific pathological signs [11, 55]. The attenuation of B. ceti 12891 porpoise strain in the present
study is thus in line with the restricted pathogenicity in porpoises. However, there are signifi-
cant discrepancies in both innate and adaptive immunity mechanisms between species [56]
and a transfer of the herein observed properties to porpoises should be made with caution.
There are approximately 35 living species of pinnipeds distributed all over the world [57]
and isolations of B. pinnipedialis have been made in seven of these [10, 12]. The cetaceans are a
large group with approximately 78 species [58] and B. ceti has been isolated from thirteen ceta-
cean species; [10, 12, 59]. Considering that brucellae have been isolated from approximately
20% of the pinniped and cetacean species, while anti-Brucella antibodies have been detected in
several more of the species [10–12], one should assume that we still have an “Ocean of Bru-
cella” to explore, and that new information related to zoonotic potential, bacteriology, serology,
genetics, host species, host-pathogen-interaction, and transmission are probably yet to come.
Supporting Information
S1 Fig. Liver bacterial counts and organ weights. Liver bacterial counts for B. pinnipedialis
12890 (open diamonds), B. ceti 12891 (crosses) and B. suis 1330 (black squares) in livers (a) of
BALB/c mice after intraperitoneal (ip) inoculation of 105 colony forming units (CFU) of bacte-
ria. Uninfected control mice received sterile phosphate buffered saline ip (black lines). Four or
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five mice were euthanized per lot at day 3, 7, 14, 21, 35, 56 and 84 post infection (day 56 and
84; only B. ceti 12891 and B. suis 1330). The number of viable bacteria was determined, and the
numbers of bacterial counts were logarithmic transformed. Liver weights (b) were determined
in parallel. Results are expressed as mean + one standard deviation. Whether CFU numbers
differed significantly between mice infected with B. suis 1330, and B. ceti 12891 or B. pinnipe-
dialis 12890, respectively, at the different times pi, are presented in Table 1. Whether liver
weights of the infected mice were significantly different from those of the uninfected control
mice, at the different times pi, is presented in S1 Table.
(TIF)
S2 Fig. Blood and faeces bacterial counts. Presence of B. pinnipedialis 12890 (open dia-
monds), B. ceti 12891 (crosses) and B. suis 1330 (black squares) per ml of blood (a) and per
gram of faeces (b) in BALB/c mice after intraperitoneal inoculation of 105 colony forming units
(CFU) of bacteria. Uninfected control mice received sterile phosphate buffered saline ip. Four
or five mice were euthanized per lot at day 3, 7, 14, 21, 35, 56 and 84 post infection (day 56 and
84; only B. ceti 12891 and B. suis 1330). The number of viable bacteria was determined. The
numbers of bacteria in the blood were logarithmic transformed, while the numbers of bacteria
in the faeces are presented as CFU/gram. Results are expressed as mean + one standard devia-
tion. Whether results differed significantly between mice infected with B. suis 1330, or B. ceti
12891 and B. pinnipedialis 12890, respectively, at the different times pi, are presented in
Table 1.
(TIF)
S3 Fig. Spleen and liver histopathology at day 14 post infection. Spleen and liver histopa-
thology in BALB/c mice after intraperitoneal (ip) inoculation of 105 of B. suis 1330, B. pinnipe-
dialis 12890 or B. ceti 12891. Uninfected control mice received sterile phosphate buffered saline
ip. Spleens (2x): a, b, c and d, (20x): e, f, g and h. Mice infected with B. suis 1330 had mildly
affected spleen architecture with small and ill-defined lymphoid follicles (lymphoid depletion),
no germinal centers and an expanded red pulp (a). A 20x enlargement of an ill-defined lym-
phoid follicle with scant numbers of lymphocytes from a B. suis 1330 infected mouse is pre-
sented (e). Mice infected with B. pinnipedialis 12890 had preserved spleen architecture with
small lymphoid follicles, some of them with germinal centers (b and f). The spleens of mice
infected with B. ceti 12891 had preserved architecture with well-demarcated lymphoid follicles,
some of them with germinal centers (c). A 20x enlargement of a lymphoid follicle with the mar-
ginal zone present from a B. ceti 12891-infected mouse is presented (g). Uninfected mouse
spleens with no lesions (2x and 20x, d and h). Livers (20x): i, j, k and l. Mice infected with B.
suis 1330 showing multiple well-defined inflammatory nodules in the liver characterized by
macrophages and neutrophils, with some of the nodules extending and coalescing with each
other (i). Mice infected with B. pinnipedialis 12890 (j) and B. ceti 12891 (k) showing small well-
demarcated granulomas scattered throughout the liver tissue. Uninfected mouse livers with no
lesions (20x, l).
(TIFF)
S4 Fig. Splenocyte supernatant cytokines. Level of interferon (IFN)-γ (a), tumor necrosis fac-
tor (TNF)-α (b) and interleukin (IL) -6 (c) in splenocyte supernatants from BALB/c mice
infected by intraperitoneal (ip) inoculation of 105 colony forming units of B. pinnipedialis
12890 (dark grey), B. ceti 12891 (black)or B. suis 1330 (light grey) 7 days earlier. Uninfected
mice received sterile phosphate buffered saline ip (white). Splenocytes were either stimulated
with the homologous HK B. pinnipedalis 12890, HK B. ceti 12891 or HK B. suis 1330, or left
unstimulated (medium). Additionally, splenocytes from uninfected mice were stimulated with
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the same HK brucellae, or left unstimulated. As controls, splenocytes from infected and unin-
fected mice were stimulated with LPS from Escherichia coli. The experiments were repeated
twice. The results are presented as mean + one standard error of the mean.  = p< 0.001, 
= p< 0.01,  = p< 0.05.
(TIFF)
S1 Table. Level of statistical difference between organ weights in uninfected and infected
mice. Level of statistical difference between spleen and liver weights in uninfected and infected
BALB/c mice after intraperitoneal (ip) inoculation of 105 colony forming units (CFU) of B. suis
1330, B. pinnipedialis 12890 or B. ceti 12891. Uninfected mice received sterile phosphate buff-
ered saline ip. Four or five mice were euthanized per lot at day 3, 7, 14, 21, 35, 56 and 84 post
infection (day 56 and 84; only B. ceti 12891 and B. suis 1330). Infected mice were compared to
uninfected mice and  = p< 0.001,  = p< 0.01,  = p< 0.05, ns = not significant, X = not
available.
(DOCX)
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